TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
OCS

Oculis Holding AG

Healthcare · Biotechnology

9.10$ -2.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Oculis Holding AG (OCS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 0.0 million CHF. Tick rows to compare them in a chart.

All figures in millions of CHF.

Tick rows to compare them in a chart (up to 4)

Income Statement OCS
Line item 2020 2021 2022 2023 2024 2025
1.0 1.0 0.9 0.9 0.7 0.0
9.3 9.6 22 29 52 –
-8.3 -8.6 -21 -28 -51 –
9.3 9.6 22 29 52 55
3.5 4.1 6.7 15 22 23
12 13 32 81 22 79
-12 -13 -32 -81 -73 -79
2.6 5.1 6.4 1.5 0.6 0.8
-15 -19 -39 -89 -86 -95
0.1 0.0 0.1 0.1 -0.2 0.2
-15 -19 -39 -89 -86 -95
-12 -13 -32 -87 -86 -93

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?